The effect of 7-Keto Naturalean™ on weight loss:: A randomized, double-blind, placebo-controlled trial

被引:12
|
作者
Zenk, JL
Helmer, TR
Kassen, LJ
Kuskowski, MA
机构
[1] Minnesota Appl Res Ctr, Chanhassen, MN 55317 USA
[2] Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Minneapolis, MN 55417 USA
来源
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 2002年 / 63卷 / 04期
关键词
weight loss; 7-oxo-DHEA; dehydroepiandrosterone; obesity;
D O I
10.1016/S0011-393X(02)80031-5
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: A natural metabolite of dehydroepiandrosterone (DHEA), 3-acetyl-7-oxo-dehydroepiandrosterone (7-oxo-DHEA), has been shown to be effective in enhancing weight loss when combined with a diet and exercise program. Objective: This study assessed the effects of a formula containing 7-oxo-DHEA, L-tyrosine, asparagus root extract, choline bitartrate, inositol, copper gluconate, manganese, and potassium iodide (7-Keto Naturalean(TM)) on weight loss, body composition, and basal metabolic rate (BMR) in overweight patients following a weight-reduction diet and exercise regimen. Methods: In this prospective, randomized, double-blind, placebo-controlled trial, healthy, overweight adults were given 7-Keto Naturalean (200 mg/d) or a placebo of maltodextrin and followed a calorie-restricted diet (105 kJ/kg) and an exercise program for 8 weeks. Body weight, body composition (by bioelectric impedance), and BMR (by indirect calorimetry) were measured at baseline, week 4, and week 8. A thyroid panel was done at baseline and week 8. Results: Of 35 healthy, overweight adults enrolled, 33 completed the study (12 men, 21 women; age, 40-69 years; body mass index [BMI], 27.0-42.7 kg/m(2)). Patients taking 7-Keto Naturalean lost significantly more weight after 8 weeks than those taking placebo (mean +/- SD loss, 2.15 +/- 2.38 kg and 0.72 +/- 2.12 kg, respectively) (P = 0.038). The change in BMI in the 7-Keto Naturalean-treated group was significant compared with the change in the placebo group (mean +/- SD decrease, 0.71 +/- 0.79 kg/m(2) and 0.01 +/- 1.05 kg/m(2), respectively) (P = 0.036). There were no other statistically significant differences in any of the other measured variables. 7-Keto Naturalean was well tolerated, and there were no significant adverse events. Conclusion: In this select population, 7-Keto Naturalean combined with a reduced-calorie diet and an exercise program resulted in a significant weight loss compared with diet and exercise alone.
引用
收藏
页码:263 / 272
页数:10
相关论文
共 50 条
  • [1] Double-blind randomized placebo-controlled trial of sibutramine
    Bray, GA
    Ryan, DH
    Gordon, D
    Heidingsfelder, S
    Cerise, F
    Wilson, K
    OBESITY RESEARCH, 1996, 4 (03): : 263 - 270
  • [2] A randomized, double-blind, placebo-controlled trial of a new weight-reducing agent of natural origin
    Thom, E
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2000, 28 (05) : 229 - 233
  • [3] Antiobesity effect of Gynostemma pentaphyllum extract (actiponin): A randomized, double-blind, placebo-controlled trial
    Park, Soo-Hyun
    Huh, Tae-Lin
    Kim, Sun-Young
    Oh, Mi-Ra
    Pichiah, P. B. Tirupathi
    Chae, Soo-Wan
    Cha, Youn-Soo
    OBESITY, 2014, 22 (01) : 63 - 71
  • [4] Effect of sibutramine on weight reduction in women with polycystic ovary syndrome:: a randomized, double-blind, placebo-controlled trial
    Lindholm, Asa
    Bixo, Marie
    Bjorn, Inger
    Wolner-Hanssen, Pal
    Eliasson, Mats
    Larsson, Anders
    Johnson, Owe
    Poromaa, Inger Sundstrom
    FERTILITY AND STERILITY, 2008, 89 (05) : 1221 - 1228
  • [5] A Randomized, Double-Blind, Placebo-Controlled Trial of Pregnenolone for Bipolar Depression
    Brown, E. Sherwood
    Park, John
    Marx, Christine E.
    Hynan, Linda S.
    Gardner, Claire
    Davila, Domingo
    Nakamura, Alyson
    Sunderajan, Prabha
    Lo, Alexander
    Holmes, Traci
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 (12) : 2867 - 2873
  • [6] The effect of β-caryophyllene on food addiction and its related behaviors: A randomized, double-blind, placebo-controlled trial
    Alizadeh, Shahab
    Djafarian, Kurosh
    Nejad, Maryam Mofidi
    Yekaninejad, Mir Saeed
    Javanbakht, Mohammad Hassan
    APPETITE, 2022, 178
  • [7] Bupropion SR enhances weight loss: A 48-week double-blind, placebo-controlled trial
    Anderson, JW
    Greenway, FL
    Fujioka, K
    Gadde, KM
    McKenney, J
    O'Neil, PM
    OBESITY RESEARCH, 2002, 10 (07): : 633 - 641
  • [8] Efficacy and safety of diacerein monotherapy in adults with obesity: A randomized, double-blind, placebo-controlled trial
    Xiang, Yingying
    Shen, Lixuan
    Xue, Yingying
    Wang, Ziwei
    Zhou, Ruonan
    Cao, Yue
    Zhu, Ziwei
    Xu, Pingyuan
    Yu, Xizhong
    Fang, Penghua
    Shang, Wenbin
    DIABETES OBESITY & METABOLISM, 2024, 26 (11) : 5293 - 5303
  • [9] Effect of green tea extract on obese women: A randomized, double-blind, placebo-controlled clinical trial
    Hsu, Chung-Hua
    Tsai, Tung-Hu
    Kao, Yung-Hsi
    Hwang, Kung-Chang
    Tseng, Ting-Yu
    Chou, Pesus
    CLINICAL NUTRITION, 2008, 27 (03) : 363 - 370
  • [10] A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial
    Jatoi, A.
    Steen, P. D.
    Atherton, P. J.
    Moore, D. F.
    Rowland, K. M.
    Le-Lindqwister, N. A.
    Adonizio, C. S.
    Jaslowski, A. J.
    Sloan, J.
    Loprinzi, C.
    ANNALS OF ONCOLOGY, 2017, 28 (08) : 1957 - 1963